NICE

Showing 15 posts of 866 posts found.

Kennedy and Drayson: parallel plans to boost UK’s innovation agenda

August 5, 2009
Research and Development NICE, healthcare

1: The Office of Life Science’s ‘Blueprint’The first to be launched was the ‘Blueprint’ – a new strategic vision aiming …

Kennedy calls for overhaul of NICE processes

July 23, 2009
Research and Development, Sales and Marketing NICE, hta

NICE has come under fire over its lack of transparency and its relationship with the industry, following an inquiry by …

NICE approves MabThera for leukaemia

July 22, 2009
Research and Development, Sales and Marketing MabThera, NICE

NICE has approved Roche's top-selling drug MabThera as a first-line treatment for the UK's most common type of leukaemia. The …

NICE bypassed in radical innovation boost

July 16, 2009
Research and Development, Sales and Marketing ABPI, Blueprint, NICE, hta

Ministers have sidestepped NICE in their bid to boost innovation in life sciences, and said certain medicines can made available …

NICE to reconsider GSK’s Tyverb

July 9, 2009
Research and Development, Sales and Marketing GSK, NICE, Tyverb

NICE is to reconsider Tyverb under its new lenient approach for end-of-life drugs, after GSK appealed its previous rejection of …

NICE takes on quality and outcomes

June 19, 2009
GP, NICE, healthcare, qof, quality

Some developments at NICE, now celebrating its 10th birthday, may have passed you by. They have moved beyond their technology …

NICE defies pressure and keeps restrictions on Alzheimer’s

June 15, 2009
Research and Development Alzheimer's, NICE

Patients with early stage Alzheimer's disease will still be denied access to drug treatment after NICE decided to retain its …

NICE and MRC to research watchdog’s methodology

June 5, 2009
NICE

Funding worth £2 million has been made available for research into how NICE can better do its job. The drug …

NICE approves Erbitux for colon cancer

June 1, 2009
Research and Development, Sales and Marketing Erbitux, NICE

NICE has approved Merck Serono's Erbitux, making it a first-line therapy for many patients with a certain type of metastatic …

Kennedy sets out views on NICE’s future

May 14, 2009
Research and Development NICE

Two stakeholder workshops which could shape NICE's future direction are to be held next week. Professor Sir Ian Kennedy has …

NICE rejects Nexavar for liver cancer

May 7, 2009
Research and Development, Sales and Marketing Bayer, NICE, Nexavar

NICE has rejected Nexavar as a treatment for liver cancer, saying it is not a cost-effective use of NHS resources. …

NHS should be ‘jewel in the crown’ for UK biotech

May 7, 2009
Research and Development NICE

The NHS could be the 'jewel in the crown' of UK medical research, if it would only assist in clinical …

NICE could ease QALY to boost innovation

April 30, 2009
Research and Development NICE

NICE could be set to dramatically change its cost-effectiveness measure and help boost innovation in the UK, according to Sir …

NICE approves Bayer’s Xarelto

April 23, 2009
Research and Development Bayer, NICE, Xarelto

NICE has approved Bayer's anti-clotting treatment Xarelto, bringing it into line with Boehringer Ingelheim's rival Pradaxa. Xarelto (rivaroxaban) was assessed …

The Gateway to Local Adoption Series

Latest content